ATE477321T1 - Aviäre telomerase reverse transkriptase - Google Patents

Aviäre telomerase reverse transkriptase

Info

Publication number
ATE477321T1
ATE477321T1 AT07703676T AT07703676T ATE477321T1 AT E477321 T1 ATE477321 T1 AT E477321T1 AT 07703676 T AT07703676 T AT 07703676T AT 07703676 T AT07703676 T AT 07703676T AT E477321 T1 ATE477321 T1 AT E477321T1
Authority
AT
Austria
Prior art keywords
telomerase reverse
aviary
reverse transcriptase
cells
nucleic acid
Prior art date
Application number
AT07703676T
Other languages
English (en)
Inventor
Philippe Erbs
Jean-Marc Balloul
Marina Kapfer
Nathalie Silvestre
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE477321T1 publication Critical patent/ATE477321T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07703676T 2006-01-05 2007-01-05 Aviäre telomerase reverse transkriptase ATE477321T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06360001 2006-01-05
EP06360047 2006-10-13
PCT/EP2007/050120 WO2007077256A1 (en) 2006-01-05 2007-01-05 Avian telomerase reverse transcriptase

Publications (1)

Publication Number Publication Date
ATE477321T1 true ATE477321T1 (de) 2010-08-15

Family

ID=38016619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07703676T ATE477321T1 (de) 2006-01-05 2007-01-05 Aviäre telomerase reverse transkriptase

Country Status (19)

Country Link
US (1) US9024003B2 (de)
EP (1) EP1979474B1 (de)
JP (2) JP5661243B2 (de)
KR (1) KR101337377B1 (de)
CN (1) CN102268413A (de)
AT (1) ATE477321T1 (de)
AU (1) AU2007204024B2 (de)
BR (1) BRPI0706836B1 (de)
CA (1) CA2636329C (de)
CY (1) CY1110860T1 (de)
DE (1) DE602007008360D1 (de)
DK (1) DK1979474T3 (de)
HR (1) HRP20100484T1 (de)
PL (1) PL1979474T3 (de)
PT (1) PT1979474E (de)
RS (1) RS51525B (de)
RU (1) RU2415867C2 (de)
SI (1) SI1979474T1 (de)
WO (1) WO2007077256A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1979474B1 (de) * 2006-01-05 2010-08-11 Transgene SA Aviäre telomerase reverse transkriptase
EP1985305A1 (de) * 2007-04-24 2008-10-29 Vivalis Aus Entenembryonen gewonnene Stammzellkulturen zur Herstellung von Impfstoffen gegen Viren
US8357531B2 (en) * 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
KR101014030B1 (ko) 2008-08-29 2011-02-14 현대자동차주식회사 와이어링 취부용 플랜지 및 제조공정
KR20120026526A (ko) * 2009-05-12 2012-03-19 트랜스진 에스.에이. 불멸화 조류 세포주 및 그의 용도
US20120309056A1 (en) 2010-02-04 2012-12-06 Leon Arnaud Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
WO2012095514A1 (en) 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
JP2014518080A (ja) 2011-06-27 2014-07-28 バルネバ 細胞のスクリーニング方法
TW201321016A (zh) 2011-09-29 2013-06-01 Transgene Sa 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（二）
TW201318637A (zh) 2011-09-29 2013-05-16 Transgene Sa 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（一）
DK3226894T3 (da) 2014-12-01 2019-10-21 Transgene Sa Stabile flydende vacciniavirus-formuleringer
RU2694318C2 (ru) * 2014-12-04 2019-07-11 Интервет Интернэшнл Б.В. Иммортализованные фибробласты эмбриона цыпленка
EP3256156B1 (de) 2015-02-13 2025-02-12 Transgene Immunotherapeutischer impfstoff und antikörperkombinationstherapie
CA3023022A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
EP3522920A2 (de) 2016-10-10 2019-08-14 Transgene SA Immuntherapeutisches produkt und mdsc-modulator-kombinationstherapie
KR102658198B1 (ko) 2017-05-15 2024-04-16 얀센 백신스 앤드 프리벤션 비.브이. 안정한 바이러스 함유 조성물
CA3061678A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
KR102684237B1 (ko) 2017-06-21 2024-07-11 트랜스진 개인 맞춤형 백신
EP3638777A4 (de) * 2017-07-13 2021-05-12 Memphis Meats, Inc. Zusammensetzungen und verfahren zur erhöhung der effizienz von zellkulturen zur nahrungsmittelherstellung
CA3111273C (en) 2018-09-06 2024-03-26 Bavarian Nordic A/S Storage improved poxvirus compositions
FR3089789B1 (fr) 2018-12-14 2022-05-27 Univ Claude Bernard Lyon Production de vaccins viraux sur une lignee cellulaire aviaire
EP3842065A1 (de) 2019-12-23 2021-06-30 Transgene Verfahren zum entwurf eines rekombinanten pockenvirus für einen therapeutischen impfstoff
BR112022017438A2 (pt) 2020-03-12 2022-10-18 Bavarian Nordic As Composições que melhoram a estabilidade do poxvírus
EP4178605A1 (de) 2020-07-13 2023-05-17 Transgene Behandlung von immundepression
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002300900A (ja) * 2001-04-05 2002-10-15 National Institute Of Advanced Industrial & Technology 腫瘍悪性化因子および腫瘍悪性化を抑制する化合物のスクリーニング方法
EP1447443A4 (de) 2001-10-31 2006-06-07 Renomedix Inst Inc Immortalisierte mesenchymzellen und ihre verwendung
JP3897717B2 (ja) * 2002-04-23 2007-03-28 オリンパス株式会社 細胞移植治療材料およびその製造方法
EP1979474B1 (de) * 2006-01-05 2010-08-11 Transgene SA Aviäre telomerase reverse transkriptase

Also Published As

Publication number Publication date
EP1979474A1 (de) 2008-10-15
AU2007204024A1 (en) 2007-07-12
US9024003B2 (en) 2015-05-05
CN102268413A (zh) 2011-12-07
DK1979474T3 (da) 2010-09-20
RU2415867C2 (ru) 2011-04-10
KR101337377B1 (ko) 2013-12-09
CY1110860T1 (el) 2015-06-10
KR20080085074A (ko) 2008-09-22
AU2007204024B2 (en) 2012-01-19
HRP20100484T1 (hr) 2010-10-31
PL1979474T3 (pl) 2011-01-31
BRPI0706836B1 (pt) 2021-05-25
BRPI0706836A2 (pt) 2011-04-05
US20100173378A1 (en) 2010-07-08
WO2007077256B1 (en) 2007-10-25
SI1979474T1 (sl) 2010-10-29
WO2007077256A1 (en) 2007-07-12
EP1979474B1 (de) 2010-08-11
CA2636329C (en) 2016-12-13
PT1979474E (pt) 2010-10-22
CA2636329A1 (en) 2007-07-12
DE602007008360D1 (de) 2010-09-23
JP2009521945A (ja) 2009-06-11
HK1122069A1 (en) 2009-05-08
JP2013027397A (ja) 2013-02-07
RS51525B (sr) 2011-06-30
JP5661243B2 (ja) 2015-01-28
RU2008125815A (ru) 2010-02-10

Similar Documents

Publication Publication Date Title
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
WO2015112767A3 (en) Novel reverse transcriptases for use in high temperature nucleic acid synthesis
DE602006018709D1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
MX2020003168A (es) Pirimidinas modificadas en la posicion 5 y su uso.
MX2014007233A (es) Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados.
BR112012012008A2 (pt) célula, ácidos nucleicos, enzimas e seu uso bem como processo para a produção de soforolipídios.
EA201071320A1 (ru) Активаторы глюкокиназы
BR112014032316A2 (pt) proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta
EA200970580A1 (ru) Таннат разагилина
BR112012015740A2 (pt) anticorpos de anti-flt3 e metodos de uso dos mesmos
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
WO2011106634A3 (en) Modified proteins and methods of making and using same
EA201171220A1 (ru) Мутанты fgf21 и их применение
JP2014064590A5 (de)
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
MX385926B (es) Proteínas de fusión de citoquinas.
WO2009039189A3 (en) Compositions comprising stat3 sirna and methods of use thereof
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
BRPI0919236A8 (pt) Terapêutica e vacinas de combinação de gas
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA200970472A1 (ru) Замещенные пиразолы, композиции, их содержащие, способ получения и применение
ATE478858T1 (de) Cyclische sulfone, die zur verwendung als bace- inhibitoren geeignet sind
ATE517900T1 (de) Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung